Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Factors associated with viral RNA shedding and evaluation of potential viral infectivity at returning to school in influenza outpatients after treatment with baloxavir marboxil and neuraminidase inhibitors during 2013/2014–2019/2020 seasons in Japan: an observational study

Fig. 5

Changes in viral RNA shedding in baloxavir-treated patients with or without PA variants. a Patients with PA variants after baloxavir treatment; b patients without PA variants after baloxavir treatment. The solid red line in each figure represents the paired samples that showed potential infectivity in the second visit collected between the 5th to 13th days after the patient's symptom onset. The cut-off value for viral RNA shedding in influenza A was 2.628 log10 copies/µL. The solid gray line represents those with negative potential infectivity below the cut-off. The vertical red dotted line represents the fifth day after symptom onset. The red numeric numbers represent the rate of positive infectivity in the upper part, and the corresponding percentage in the lower part

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us